<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-molecules-25-03830">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vatansever</surname>
    <given-names>E.C.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kratch</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>Drelich</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cho</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Mellot</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tseng</surname>
    <given-names>C.T.K.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>W.R.</given-names>
   </name>
  </person-group>
  <article-title>Targeting the SARS-CoV-2 Main Protease to Repurpose Drugs for COVID-19</article-title>
  <source>BioRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.05.23.112235</pub-id>
 </element-citation>
</ref>
